TRT / RTR Design [RSABE / ABEL]

posted by mittyri – Russia, 2017-05-02 18:38  – Posting: # 17295
Views: 5,620

Dear Yura,

you should use all data included in PK analysis (ie all subjects) for CI estimation.
To extent the limits you need to calculate variability of RR, that is, 50% of subjects.
A hint: even if you try to calculate variability of RR for overall dataset, the majority of software (at least SAS PHX, R) is smart enough not to include the subjects with one R.

» The appropriate sample size must be.
» Alpha correction.
what did you mean here?

Kind regards,
Mittyri

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,302 posts in 4,102 threads, 1,316 registered users;
online 4 (1 registered, 3 guests [including 4 identified bots]).

Restlessness is discontent –
and discontent is the first necessity of progress.
Show me a thoroughly satisfied man –
and I will show you a failure.    Thomas Alva Edison

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5